Clinical Trials Listing Service

Be at the peak of asthma research: Join the ALTA Study

Last updated: December 22, 2023
Sponsor: Astra Zeneca (PAREXEL)
Overall Status: Active - Recruiting

Phase

3

Condition

Asthma

Treatment

N/A

Clinical Study ID

TX322058
D693C00017
  • Ages 18-100
  • All Genders

Study Summary

North Carolina Clinical Research is enrolling adult asthmatics to evaluate an investigational study medication.

Eligibility Criteria

Inclusion

Inclusion Criteria

We are looking for people who:

  • Are 18 years of age or older
  • Have had asthma for at least 6 months
  • Have been using short-acting albuterol inhaler as their only asthma treatment for the past 4 weeks
  • Have not used oral or injected steroids in the past 3 months

Qualified participants may receive:

  • Investigational study medication and study-related care at no cost (insurance is not required)
  • Compensation up to $1450 for study-related time and travel.

There are other criteria that you will need to meet to qualify, which the study team will discuss with you

Study Design

Study Start date:
October 02, 2023
Estimated Completion Date:
April 01, 2024

Study Description

The ALTA Study is being carried out to better understand the potential effects of an investigational study drug, called PT027, on treating acute airway obstruction (narrowing of the airways). PT027 contains albuterol, which has been used for treating asthma for over 40 years. PT027 also contains the anti-inflammatory drug, budesonide, which has been used in asthma treatment for over 30 years. You will be asked to breathe in a sugar called mannitol via an inhaler both before and after you receive the investigational drugs. Inhaling mannitol may help researchers to find out if PT027 is safe and effective for treating acute airway obstruction. If you join the ALTA study, you will need to attend the study center 3 times to receive the study treatment and have some tests and assessments, including:  Routine medical tests, overall health checks and checking the symptoms of your asthma. A screening visit of 5 hours to check if you are eligible to enter the study.  Two study center visits of 10-12 hours each where you will receive the study treatment.

Connect with a study center

  • North Carolina Clinical Research

    Raleigh, NC 27607
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.